FEASIBILITY STUDY OF WEB-BASED ACADEMIC INFORMATION SYSTEMS AT BHAKTI SEMESTA SALATIGA POLYTECHNIC USING THE FEASIBILITY METHOD OF TELOS
Compiler · 2022
DOI: 10.28989/compiler.v11i2.1257 ↗Kurz gefasst
Fachartikel in der Zeitschrift Compiler, 2022. Verfasst von Danis Putra Perdana und 2 weiteren Autor:innen. Die Arbeit nennt 11 Literaturangaben.
Abstract (Originalsprache)
In the process of developing information systems, there are often problems that are detrimental in terms of time and money in an organization. Bhakti Semesta Polytechnic, which is a polytechnic that was only established in 2021, needs to develop an Academic Information System after observations and interviews with the academic community have been carried out, so that development can run according to needs and does not cause losses. The feasibility test is carried out using the Telos method. This method is used to determine the feasibility of a project with several criteria, namely Technical, Economy, Legal, Operational and Schedule. The results of this study indicate the value of the feasibility factor is 8.4 with an evaluation design for developing a feasible information system (B) and the risk of developing a system is relatively low
Zitieren
APA
Perdana, D. P., Wulan, P. I. D. C., & Fauzi, R. (2022). FEASIBILITY STUDY OF WEB-BASED ACADEMIC INFORMATION SYSTEMS AT BHAKTI SEMESTA SALATIGA POLYTECHNIC USING THE FEASIBILITY METHOD OF TELOS. Compiler. https://doi.org/10.28989/compiler.v11i2.1257
Vancouver
Perdana DP, Wulan PIDC, Fauzi R. FEASIBILITY STUDY OF WEB-BASED ACADEMIC INFORMATION SYSTEMS AT BHAKTI SEMESTA SALATIGA POLYTECHNIC USING THE FEASIBILITY METHOD OF TELOS. Compiler. 2022. doi:10.28989/compiler.v11i2.1257
BibTeX
@article{Perdana2022,
author = {Perdana, Danis Putra and Wulan, Puspa Ira Dewi Candra and Fauzi, Rofiq},
title = {FEASIBILITY STUDY OF WEB-BASED ACADEMIC INFORMATION SYSTEMS AT BHAKTI SEMESTA SALATIGA POLYTECHNIC USING THE FEASIBILITY METHOD OF TELOS},
journal = {Compiler},
year = {2022},
doi = {10.28989/compiler.v11i2.1257}
}
EUVIMED